C M Pinsky|H F Oettgen - JoVE Visualize

Showing results (91-100 of 177) with videos related to

Pageof 18

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1979

Macrophage factor controlling differentiation of B cellsM K Hoffmann, S Koenig, R S Mittler, et al.

Cellular Immunology|March 1, 1983

Characterization of IL-2-dependent cytotoxic T-cell clones. II. Cell-surface phenotypes, histochemical and ultrastructural propertiesM A Palladino, A M Carroll, M De Sousa, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 1, 1974

Effects of dialyzable transfer factor in patients with breast cancerH F Oettgen, L J Old, J H Farrow, et al.

Cancer|August 1, 1987

Toxicity of intravesical BCG and its management in patients with superficial bladder tumorsE Orihuela, H W Herr, C M Pinsky, et al.

European Journal of Cancer & Clinical Oncology|May 1, 1984

Corynebacterium parvum toxicity in patients with limited and advanced malignancyY Hirshaut, C M Pinsky, H J Wanebo, et al.

Journal of Biological Response Modifiers|October 1, 1984

Treatment of immunodeficiency with interleukin-2: initial explorationR Mertelsmann, K Welte, C Sternberg, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patientsP O Livingston, E J Natoli, M J Calves, et al.

The Journal of Experimental Medicine|July 1, 1983

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanomaA N Houghton, H Brooks, R J Cote, et al.

The Journal of Experimental Medicine|April 1, 1982

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibodyC S Pukel, K O Lloyd, L R Travassos, et al.

Cancer|December 15, 1980

Immunotherapy with oral BCG and serial immune evaluation in childhood lymphoblastic leukemia following three years of chemotherapyM Haghbin, S Cunningham-Rundles, H T Thaler, et al.

Pageof 18

Showing results (91-100 of 177) with videos related to

Sort By:

Pageof 18

Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1979

Macrophage factor controlling differentiation of B cellsM K Hoffmann, S Koenig, R S Mittler, et al.

Cellular Immunology|March 1, 1983

Characterization of IL-2-dependent cytotoxic T-cell clones. II. Cell-surface phenotypes, histochemical and ultrastructural propertiesM A Palladino, A M Carroll, M De Sousa, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 1, 1974

Effects of dialyzable transfer factor in patients with breast cancerH F Oettgen, L J Old, J H Farrow, et al.

Cancer|August 1, 1987

Toxicity of intravesical BCG and its management in patients with superficial bladder tumorsE Orihuela, H W Herr, C M Pinsky, et al.

European Journal of Cancer & Clinical Oncology|May 1, 1984

Corynebacterium parvum toxicity in patients with limited and advanced malignancyY Hirshaut, C M Pinsky, H J Wanebo, et al.

Journal of Biological Response Modifiers|October 1, 1984

Treatment of immunodeficiency with interleukin-2: initial explorationR Mertelsmann, K Welte, C Sternberg, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patientsP O Livingston, E J Natoli, M J Calves, et al.

The Journal of Experimental Medicine|July 1, 1983

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanomaA N Houghton, H Brooks, R J Cote, et al.

The Journal of Experimental Medicine|April 1, 1982

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibodyC S Pukel, K O Lloyd, L R Travassos, et al.

Cancer|December 15, 1980

Immunotherapy with oral BCG and serial immune evaluation in childhood lymphoblastic leukemia following three years of chemotherapyM Haghbin, S Cunningham-Rundles, H T Thaler, et al.

Pageof 18